G & CTI HEALTHCARE COMPANIES
Within the College, our objective is to bring together industrialists in the health sector in order to jointly establish concrete recommendations, to bring them with one voice to decision-makers and to make them known to the general public. One of our major axes consists in increasing the attractiveness of France in the field of gene and cell therapies, to position it as a leader in innovation.
large pharma laboratories
of Consulting Companies
PRESIDENT OF THE COLLEGE HEALTH ENTERPRISES
After graduating with a doctorate in veterinary medicine, I joined the pharmaceutical industry over 20 years ago. Since September 2016, I have the pleasure of leading the Rare Diseases department of Pfizer France. A role that plunges me directly into the heart of the subject of innovative therapies. This fascinating theme led me to invest myself in the presidency of the College "Healthcare companies".
In addition to this, you will need to know more about it.
Proud of the dynamism that has animated the College since its inception, I will make sure that our commitments contribute to achieving the mission of the Think Tank G & CTI.
EVERYBODY HAS A WORD TO SAY
Consolidate genetic and cellular therapies as an essential added value from now on in policies and investments in research as well as in public health. Make France the European leader in the innovative therapy sector. Two challenges among others that pushed me to join and get involved in the actions carried out by the G & CTi.
Member of G & CTi and Eurobiomed Biocluster
While gene therapy is at the dawn of its increasingly broad therapeutic use, we must collectively do everything possible to be one of the host countries for this new technology and to support the transformations induced by these innovations. G & CTI embodies this "Collectively".
Director of Public Affairs - Pfizer France
Member of G & CTI
THE COLLEGE'S 2021 OBJECTIVES
Ensure relevant production from the college and working groups to capitalize on future opportunities for public and political debates
Provide sufficient scientific background to all stakeholders to make informed decisions
COURSES OF REFLECTION
Guarantee fair remuneration for all stakeholders and access to patients
Ensure competitive organic production on European territory